ArticleChemistry & biodiversity2026
Depigmenting Effects of Vitex rotundifolia Cone Essential Oil in Melanocytes and Its Chemical Composition.
Article in Chemistry & biodiversity, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Vitex rotundifolia L.f. (VRL) is a plant belonging to the Verbenaceae family with antipyretic, analgesic, and anti-inflammatory properties, but research on the melanocyte-targeted skin depigmenting-related responses of VRL is lacking. In this study, VRL cone essential oil (VRLCEO) was obtained through steam distillation, and its effects on melanin synthesis and transport-related responses were investigated. Gas chromatography-mass spectrometry analysis identified 15 components from VRLCEO. In all biological activity experiments, VRLCEO was used at noncytotoxic concentrations (≤ 50 µg/mL) to ensure cell viability. VRLCEO inhibited serum-induced cell proliferation of B16BL6 mouse melanoma cells. VRLCEO suppressed tyrosinase enzyme activity and melanin synthesis in B16BL6 melanoma cells induced by α-MSH. VRLCEO also reduced the expression of MITF, tyrosinase, and TRP-2 proteins in α-melanocyte-stimulating hormone (α-MSH)-stimulated B16BL6 cells, but did not affect TRP-1 protein expression. Moreover, it increased the p38 MAPK and ERK1/2 phosphorylation levels in α-MSH-exposed B16BL6 cells, but not the JNK phosphorylation level. Furthermore, VRLCEO decreased α-MSH-upregulated Rab27a and melanophilin expression in B16BL6 cells. Therefore, VRLCEO may exert an anti-pigmentation effect by inhibiting melanin production and transfer in melanocytes. Accordingly, VRLCEO may be a natural material for the development of skin whitening agents.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.